Pharvaris (PHVS) Change in Taxes (2021 - 2026)
Pharvaris (PHVS) posted Change in Taxes of -$150365.9 for Q1 2026, up 93.81% on a QoQ basis from -$2.4 million in Q4 2025, and down 163.74% year-over-year from $235894.6 in Q1 2025.
Pharvaris (PHVS) Change in Taxes (2021 - 2026) Analysis & Trends
Pharvaris' Change in Taxes history runs 6 years deep, the most recent figure standing at -$150365.9 for Q1 2026.
- Quarterly Change in Taxes fell 163.74% year-over-year to -$150365.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 100.01% YoY) and the FY2025 annual result came in at -$2.5 million, up 18.19% from the prior year.
- Change in Taxes was -$150365.9 for Q1 2026 at Pharvaris, up from -$2.4 million in the prior quarter.
- Across five years, Change in Taxes topped out at $1224.2 billion in Q3 2024 and bottomed at -$1200.5 billion in Q2 2024.
- A 5-year average of $1.8 billion and a median of -$150365.9 in 2026 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2022 — Change in Taxes tumbled 16004.73% — and 2023, when it surged 207225949.77%.
- Pharvaris' Change in Taxes stood at $17565.6 in 2022, then sank by 1801.86% to -$298941.3 in 2023, then plunged by 48.96% to -$445296.5 in 2024, then sank by 445.88% to -$2.4 million in 2025, then surged by 93.81% to -$150365.9 in 2026.
- Business Quant data shows PHVS's Change in Taxes at -$150365.9 in Q1 2026, -$2.4 million in Q4 2025, and $235894.6 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | -150,365.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150,365.89 |
| Mar 31, 2026 | -150,365.89 |
| Dec 31, 2025 | -2.43 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Mar 31, 2025 | 235,894.55 |
| Mar 31, 2025 | 235,894.55 |
| Dec 31, 2024 | -445,296.53 |
| Dec 31, 2024 | -445,296.53 |
| Sep 30, 2024 | 1,224.25 Bn |
| Sep 30, 2024 | 1,224.25 Bn |
| Jun 30, 2024 | -1,200.47 Bn |
| Jun 30, 2024 | -1,200.47 Bn |
| Mar 31, 2024 | -65,184.97 |
| Mar 31, 2024 | -65,184.97 |
| Dec 31, 2023 | -298,941.30 |
| Dec 31, 2023 | -298,941.30 |
| Sep 30, 2023 | 417.97 Bn |
| Sep 30, 2023 | 417.97 Bn |
| Jun 30, 2023 | -418.10 Bn |
| Jun 30, 2023 | -418.10 Bn |